Estimating The Impact Associated To The Use Omalizumab In The Treatment of Severe Persistent Allergic Asthma In Portugal – Evaluating Outcomes And Treatment Costs Using Real World Data From Portuguese Patients

Nov 1, 2016, 00:00 AM
Section Title : Disease-Specific Studies
Section Order : 1131
First Page : A555
HEOR Topics :
Tags :
Regions :